Skip to main content
Clinical Trials/NCT03082326
NCT03082326
Completed
N/A

The Critical Care Ultrasound Based Characteristic of Hemodynamic and Lung Pathology in Early Stage of Shock in ICU: The Epidemic and Prognostic Value

West China Hospital1 site in 1 country181 target enrollmentApril 5, 2016
ConditionsShock

Overview

Phase
N/A
Intervention
Not specified
Conditions
Shock
Sponsor
West China Hospital
Enrollment
181
Locations
1
Primary Endpoint
all cause mortality
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Shock is a common condition in critical care unit (ICU). It is extremely important that the patient accepts early goal-directed therapy (EGDT) treatment in the early stage of shock. However, several studies failed to demonstrate that the well used variables such as CVP and others could direct to a better treatment. In recent years, critical care ultrasound (CCUS) has been respected as a reliable noninvasive tool and widely used in ICU practice. With CCUS the investigators can accurately acquired the detailed information of the characteristic of the hemodynamics and lung pathology (the systole and diastole function, volume status, valve insufficiency, lung, edema, consolidation, and pleural effusion, etc.). To the investigators knowledge, there is no study investigating the epidemic of such ultrasonic variables and its value to predict to outcome. The aim of this study is to investigate the epidemic and the prognostic value of CCUS Based Characteristic of Hemodynamic and Lung pathology in Early Stage of Shock in patients admitted in ICU.

Detailed Description

Adult patients who admitted to the intensive care unit of West China hospital of sichuan university with shock from April 2016 to April 2017 enrolled.

Registry
clinicaltrials.gov
Start Date
April 5, 2016
End Date
June 6, 2017
Last Updated
8 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

tongjuan ZOU

Doctor

West China Hospital

Eligibility Criteria

Inclusion Criteria

  • SBP\<90 mm Hg or MAP \<70 mm Hg or SBP decrease \>40mmHg or need vasoactive drugs;
  • Skin that is cold and clammy, capillary refill time \>4.5s, urine output of \<0.5ml/Kg.hr and lactate\>2mmol/L;
  • SHOCK presented within 6 hr.

Exclusion Criteria

  • \<18 years old;
  • Patient or family member refuse to be enrolled.

Outcomes

Primary Outcomes

all cause mortality

Time Frame: 28 days

Secondary Outcomes

  • ICU length of stay(through study completion, an average of 28 days)
  • length of mechanical ventilation(through study completion, an average of 28 days)
  • hospital length of stay(through study completion, an average of 28 days)

Study Sites (1)

Loading locations...

Similar Trials